Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial
- 24 May 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 27 (5), 634-638
- https://doi.org/10.1017/s1092852921000572
Abstract
Background The aim of this study is to examine the effects of quetiapine as an adjuvant treatment for obsessive-compulsive (OC) symptoms in patients with bipolar disorder (BD) type I. Methods In this 8-week double-blind placebo-controlled randomized clinical trial, 47 patients with BD in euthymic phase that had OC symptoms were randomly allocated to receive either quetiapine or placebo plus their routine medications (lithium + clonazepam). Yale-Brown Obsessive-Compulsive Scale (YBOCS) was used to assess the outcomes. Adverse effects were also recorded. Results Of 47 BD patients with OC symptoms that were randomly allocated in two groups of quetiapine (n = 24) and placebo group (n = 23), 40 patients (20 in quetiapine group and 20 in placebo group) completed the trial. Throughout the trial, the mean score of YBOCS in the quetiapine group dropped from 24.37 +/- 1.51 to 15.26 +/- 1.16 (P < .001) and in the placebo group decreased from 24.21 +/- 1.33 to 23.94 +/- 1.66 (P = 1.97). At the end of the study, 12 (60%) patients in the quetiapine group and 1 (5%) patient in the placebo group had more than 34% decline in YBOCS score (P < .001). No serious adverse effects were reported in two groups. Conclusions Our double-blind placebo-controlled clinical trial showed that quetiapine may be an effective adjuvant agent for reducing OC symptoms in BD patients.Keywords
This publication has 32 references indexed in Scilit:
- Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trialsMolecular Psychiatry, 2020
- Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorderInternational Clinical Psychopharmacology, 2020
- Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trialsThe British Journal of Psychiatry, 2016
- Comorbid obsessive compulsive disorder in patients with bipolar-I disorderJournal of Affective Disorders, 2015
- Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trialJournal of Affective Disorders, 2014
- Pharmacological Treatment of Obsessive-Compulsive DisorderPsychiatric Clinics of North America, 2014
- Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive DisorderBritish Journal of Psychology, 2009
- Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2007
- Quetiapine in the treatment of schizophrenia and related disordersNeuropsychiatric Disease and Treatment, 2007
- Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disordersPsychiatry Research, 1995